Another acute-phase protein that serves as a biomarker of endothelial dysfunction is serum amyloid A (SAA), a family of acute-phase apolipoproteins encoded by four genes—SAA1, SAA2, SAA3, and SAA4—and produced primarily by hepatocytes and macrophages. This evidence concerns the gene SAA1 and endothelial dysfunction.